The new commercial name of the COVID-19 VACCINE MODERNA is spikevax

The new commercial name of the COVID-19 VACCINE MODERNA is spikevax

In connection with a Mag's letter. FARM Bogdan Kirilov, Executive Director of the Medicines Executive Agency, we will notify you that a new trade name of [COVID-19 VACCINE MODERNA] (https://www.bda.bg/images/stories/documents/vaccinesLy- COVID-19-VACCINE-MODERNA-EPAR-PRODUCT-INFORMATION_BG.PDF) is SPIKEVAX.

1 . Name of medicinal product

SPIKEVAX injection dispersion Irna vaccine against COVID-19 (nucleoside modified)

2 . QUALITATIVE AND QUANTITATIVE COMPOSITION

This is a multidose vial that contains 10 doses of 0.5 ml. One dose (0.5 ml) contains 100 micrograms of information RNA (mRNA) (included in SM-102 lipid nanoparticles). Single-chain, 5'-CPN (mRNA) produced using a cell-free in vitro transcription from the respective DNA matrices encoding the SARS-COV-2 viral protein.

КРАТКАТА ХАРАКТЕРИСТИКА НА ПРОДУКТА МОЖЕТЕ ДА ПРОЧЕТЕТЕ И ТУК



Lastest news


Active campaigns

Национална кампания на БЛС срещу насилието над медици

Български лекарски съюз рестартира националната си кампания срещу насилието над медици #ПребориГнева със серия от обучения, които са разработени от психолози на Лаборатория за психично здраве - ВМА

Code Health TV
SatHealth
CME Academy
Medicalnews
Cluster
Credoweb Learning Modul
Осцилококцинум

International partners

IAMRA
WMA- World Medical Association
FEMS European Federation of Salaried Doctors
CPME The Standing Committee of European Doctors
UEMS European Union of Medical Specialists